Author

A. Portyanko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Martin-Bernabe· 1 shared A. Mezheyeuski· 1 shared B. Glimelius· 1 shared B. Nodin· 1 shared C. Hedner· 1 shared C. Larsson· 1 shared D. Borg· 1 shared F. Ponten· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Martin-Bernabe

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 24, 2021

The ratio of cytotoxic lymphocytes to M2-like macrophages is prognostic in immunogenic tumors

A. Mezheyeuski, M. Backman, J. Mattsson…·T. Sjöblom

The paper identifies a prognostic signature based on the ratio of cytotoxic lymphocytes to M2-like macrophages in tumor microenvironments, showing better survival prediction than existing immune scores in colon cancer and other high-mutation burden cancers.

DOI 10.1101/2021.03.24.436814

humanbulk RNA-seq

𝕏 PostBluesky